MedTrace Logo

3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI

NCT04570345 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1002

Last updated 2020-12-22

No results posted yet for this study

Summary

To compare the clinical outcomes of dual antiplatelet therapy with aspirin and P2Y12 receptor inhibitor vs. ticagrelor monotherapy at 3 months after PCI in patients with ST-elevation myocardial infarction.

Conditions

  • ST Elevation Myocardial Infarction

Interventions

DRUG

ticagrelor monotherapy

• Drug: ticagrelor monothearpy after first 3 months dual therapy

DRUG

Aspirin with P2Y12 receptor inhibitor

• Drug: aspirin plus ticagrelor dual therapy during 12 months

Sponsors & Collaborators

  • Dong-A University

    lead OTHER

Principal Investigators

  • Kyungil Park, Ph.D · Dong-A University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-08-31
Completion
2022-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04570345 on ClinicalTrials.gov